Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Change in Acquisitions & Divestments (2023 - 2025)

GeneDx Holdings has reported Change in Acquisitions & Divestments over the past 3 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $2.1 million for Q4 2025, up 108.47% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (up 243.09% YoY), and the annual figure for FY2025 was $2.1 million, up 243.09%.
  • Change in Acquisitions & Divestments for Q4 2025 was $2.1 million at GeneDx Holdings, up from -$26.7 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for WGSWW hit a ceiling of $17.8 million in Q4 2023 and a floor of -$26.7 million in Q3 2025.
  • Median Change in Acquisitions & Divestments over the past 3 years was $8.1 million (2024), compared with a mean of $2.3 million.
  • Peak annual rise in Change in Acquisitions & Divestments hit 2229.43% in 2025, while the deepest fall reached 264.49% in 2025.
  • GeneDx Holdings' Change in Acquisitions & Divestments stood at $17.8 million in 2023, then tumbled by 237.09% to -$24.4 million in 2024, then surged by 108.47% to $2.1 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $2.1 million (Q4 2025), -$26.7 million (Q3 2025), and $12.8 million (Q2 2025) per Business Quant data.